oncology
Research

News in brief: Pancreatic cancer priming may enhance response to chemo; Call to implement PROs in real world cancer care; Cancer patients can’t survive on benefits

Pancreatic cancer priming may enhance response to chemo Priming the pancreatic cancer environment by blocking molecules that cause tumour stiffness and growth may make cancer more responsive to chemotherapy, according to an Australian-led study. Short-term focal adhesion kinase (FAK) inhibition enhanced PDAC gemcitabine/nab-paclitaxel (Abraxane) sensitivity in  pancreatic ductal adenocarcinoma (PDAC) models, researchers at the Garvan ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic